AWM
MDT icon

Abound Wealth Management’s Medtronic MDT Stock Holding History

Abound Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Sell
165
-159
-49% -$12.8K ﹤0.01% 435
2026
Q1 		$28.1K Sell
324
-11
-3% -$1.05K 0.01% 334
2025
Q4 		$32.2K Buy
335
+120
+56% +$11.7K 0.01% 287
2025
Q3 		$20.5K Buy
215
+56
+35% +$5.15K 0.01% 353
2025
Q2 		$13.9K Sell
159
-14
-8% -$1.19K ﹤0.01% 388
2025
Q1 		$15.6K Sell
173
-73
-30% -$6.53K 0.01% 335
2024
Q4 		$19.7K Sell
246
-63
-20% -$5.45K 0.01% 282
2024
Q3 		$27.8K Buy
309
+51
+20% +$4.29K 0.01% 241
2024
Q2 		$20.3K Hold
258
– – 0.01% 249
2024
Q1 		$22.5K Sell
258
-84
-25% -$7.17K 0.01% 227
2023
Q4 		$28.2K Buy
342
+154
+82% +$11.7K 0.01% 206
2023
Q3 		$14.7K Sell
188
-72
-28% -$6.03K 0.01% 268
2023
Q2 		$22.9K Sell
260
-92
-26% -$7.92K 0.01% 202
2023
Q1 		$28.4K Buy
352
+208
+144% +$17K 0.01% 171
2022
Q4 		$11.2K Sell
144
-27
-16% -$2.19K 0.01% 249
2022
Q3 		$13.8K Buy
+171
New +$15.4K 0.01% 240

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Abound Wealth Management's MDT Position: Q2 2026 in Review

Abound Wealth Management reduced its Medtronic (MDT) stake by 49% in Q2 2026, selling an estimated $12.8K and leaving 165 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #435.

Abound Wealth Management first reported a position in MDT in Q3 2022 and has held it in 16 quarters since. The position peaked at $32.2K in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Abound Wealth Management held 165 shares of Medtronic worth $12.9K as of Q2 2026.
  • Abound Wealth Management sold 159 Medtronic shares in Q2 2026, an estimated $12.8K.
  • Medtronic made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #435 holding.
  • Abound Wealth Management first reported a position in Medtronic in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Medtronic position peaked at $32.2K in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.